Un monitorage cardiaque à domicile est maintenant accessible à l’ensemble des Canadiens grâce à Icentia
19 janv. 2021 08h56 HE | Icentia Inc
QUÉBEC, 19 janv. 2021 (GLOBE NEWSWIRE) -- Alors même que la pandémie s’accroît, Icentia Inc., une entreprise technologique canadienne de premier plan spécialisée dans le monitorage cardiaque...
logo Icentia.png
Home-based Heart Monitoring Now Available to All Canadians Through Icentia
19 janv. 2021 08h56 HE | Icentia Inc
QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide...
InCarda Logo.png
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
19 janv. 2021 08h05 HE | InCarda Therapeutics, Inc.
SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
Bio-Sig-Logo-horiz.jpg
BioSig to Present at the 26th Annual International AF Symposium
15 janv. 2021 09h32 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig PURE EP System Featured in the Editorial of EP Lab Digest
14 janv. 2021 09h32 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Leading industry publication calls attention to ongoing challenges in the electrophysiology labPURE EP System is highlighted as a novel technological...
Bio-Sig-Logo-horiz.jpg
BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions
13 janv. 2021 09h32 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 13, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana
12 janv. 2021 09h32 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference
06 janv. 2021 10h00 HE | BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company developing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota
18 déc. 2020 08h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Achieves First Commercial Sale of Three PURE EP Systems
11 déc. 2020 07h30 HE | BioSig Technologies, Inc.
Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...